Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Austria

Research and Innovation Action · Running

canSERV Providing cutting edge cancer research services across Europe

Coordinator
Biobanks and Biomolecular Resources Research Infrastructure Consortium (bbmri-Eric), Austria
Runs
1 September 2022 to 28 February 2027
Status
Running
EU funding
€14.9m
Total cost
€14.9m
Partners
19 organisations in 10 countries
Type
Research and Innovation Action
Grant agreement
101058620

What the project is doing

In the project's own words, from its summary on CORDIS.

canSERVs mission is to make cutting-edge and customised research services available to the cancer research community EU wide, enable innovative R&D projects and foster precision medicine for patients benefit across Europe. By connecting, coordinating, and aligning existing oncology and complimentary research infrastructures (RIs) and providing services in a synergistic way transnationally, canSERV will capitalise on the critical mass of experts and cutting-edge services offered by canSERVs RIs and their extended network. canSERV brings together world-class European life science RIs (BBMRI, EURO-BIOIMAGING, ELIXIR, EU-IBISBA, EuroPDX, EU-OPENSCREEN, INSTRUCT, EATRIS, INFRAFRONTIER, EMBRC, ECRIN, EATRIS, MIRRI, ARIE, CCE, EORTC and IARC) that collectively not only covers all aspects along the development pipeline for oncology, but is also capable of interconnecting these technologies providing users a guidance for navigating them through the entire translational value chain.

A patient organisation or resp. governance board members will bring the patients perspective, while the PNO Innovation and PNO Life Sciences & Health will provide valuable input regarding stakeholder engagement, and project management activities. A common access management system (CAMS) will be developed based on mature solutions from INSTRUCT and BBMRI. The CAMS will provide a method for selection of services, construction and submission of research proposals, multi-step review of research proposals, and tracking of the access process from approval through delivery to conclusion.

Through a united user-intuitive transnational access where a united catalogue of oncology services will be offered, our users will have access to a comprehensive service portfolio. As our ambition is to scale up canSERV to a pan-European collaboration of RIs for accelerating the development and implementation of solutions for the cancer patient community, the sustainability of this network beyond the end of the project will also be addressed.

Topics

Who is involved

OrganisationCityCountryRole
Biobanks and Biomolecular Resources Research Infrastructure Consortium (bbmri-Eric)GrazAustriaCoordinator
European Cancer Patient CoalitionBruxelles / BrusselBelgiumParticipant
Organisation Europeenne Pour La Recherche Et Le Traitement Du Cancer AisblBruxelles / BrusselBelgiumParticipant
European Infrastructure of Open Screening Platforms for Chemical Biology European Research Infrastucture Consortium (eu-Openscreen Eric)BerlinGermanyParticipant
European Molecular Biology LaboratoryHeidelbergGermanyParticipant
Infrafrontier EricNeuherbergGermanyParticipant
Pno Innovation GmbHMunchenGermanyParticipant
Fundacio Privada Institut D'investigacio Oncologica De Vall-Hebron (vhio)BarcelonaSpainParticipant
Euro-Bioimaging EricTurkuFinlandParticipant
Centre International De Recherche Sur Le CancerLyon 7emeFranceParticipant
Ecrin European Clinical Research Infrastructure NetworkParisFranceParticipant
European Marine Biological Resource Centre European Research Infrastructure ConsortiumParisFranceParticipant
Universita Degli Studi Di TorinoTorinoItalyParticipant
Eatris EricAmsterdamNetherlandsParticipant
PNO Life Sciences & Health B.V.RijswijkNetherlandsParticipant
Wageningen UniversityWageningenNetherlandsParticipant
Universidade Do MinhoBragaPortugalParticipant
Instruct-EricOxfordUnited KingdomParticipant
The University of ManchesterManchesterUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI